Your browser doesn't support javascript.
loading
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer.
Gafita, Andrei; Djaileb, Loïc; Rauscher, Isabel; Fendler, Wolfgang P; Hadaschik, Boris; Rowe, Steven P; Herrmann, Ken; Calais, Jeremie; Rettig, Matthew; Eiber, Matthias; Weber, Manuel; Benz, Matthias R; Farolfi, Andrea.
Afiliação
  • Gafita A; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Djaileb L; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Rauscher I; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Fendler WP; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Hadaschik B; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Rowe SP; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Herrmann K; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Calais J; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Rettig M; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Eiber M; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Weber M; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Benz MR; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
  • Farolfi A; From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology (A.G., L.D., J.C., M.R.B., A.F.), Department of Medicine and Urology, David Geffen School of Medicine (M.R.), and Department of Radiological Sciences (M.R.B.), University of California-Los Angeles
Radiology ; 308(1): e222148, 2023 07.
Article em En | MEDLINE | ID: mdl-37432081
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Qualitative_research / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Qualitative_research / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article